Home
InterMune, Inc.

InterMune, Inc. Market Share Analysis for May 2026

see relevant content for intermune.com

Health > Biotechnology and Pharmaceuticals

Domainintermune.com

Year Founded1998

Employees201 - 500

Annual Revenue$200M - $500M

InterMune, Inc.

InterMune, Inc. (including company regionals)

intermune.com

See more website traffic and engagement information

InterMune, Inc. Revenue up to May 2026 is 200M - 500M

revenue generated by InterMune, Inc. top domains

InterMune, Inc. top domains revenue over 3 years

Revenue for InterMune, Inc. top domains

intermune.com200M - 500M

See more with Sales Intelligence

Total visits to InterMune, Inc.'s top domains

Understand InterMune, Inc. market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in InterMune, Inc.'s top domains

Analyze InterMune, Inc. engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on InterMune, Inc.'s top domains

See how InterMune, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

InterMune, Inc. top competitors by domain

Top similar sites in May 2026, ranked by their affinity

exelixis.comCompany NameExelixisEmployees1001 - 5000HQUnited States, California, AlamedaAnnual revenue> $1BTotal visits571.8KHealth > Biotechnology and Pharmaceuticals

Top technologies used by InterMune, Inc.

These are the website technologies, by industry, used by InterMune, Inc. top domains

Advertising (2)

Google Adsense

Conversion & Analytics (2)

Google Analytics

Audio Video Media (1)

Flowplayer

Mobile (1)

Meta Viewport

More Technologies

1

See all

News & Signals from InterMune, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsRoche acquired Intermune for $8.3B on Jan 1st '14.The medication became part of the company’s pipeline in 2014, after Roche acquired Brisbane, Calif.-based InterMune, in an $8.3 billion deal.